» Articles » PMID: 19549910

MiR-15a and MiR-16 Are Implicated in Cell Cycle Regulation in a Rb-dependent Manner and Are Frequently Deleted or Down-regulated in Non-small Cell Lung Cancer

Overview
Journal Cancer Res
Specialty Oncology
Date 2009 Jun 25
PMID 19549910
Citations 179
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNA) are negative regulators of gene expression at the posttranscriptional level, which are involved in tumorigenesis. Two miRNAs, miR-15a and miR-16, which are located at chromosome 13q14, have been implicated in cell cycle control and apoptosis, but little information is available about their role in solid tumors. To address this question, we established a protocol to quantify miRNAs from laser capture microdissected tissues. Here, we show that miR-15a/miR-16 are frequently deleted or down-regulated in squamous cell carcinomas and adenocarcinomas of the lung. In these tumors, expression of miR-15a/miR-16 inversely correlates with the expression of cyclin D1. In non-small cell lung cancer (NSCLC) cell lines, cyclins D1, D2, and E1 are directly regulated by physiologic concentrations of miR-15a/miR-16. Consistent with these results, overexpression of these miRNAs induces cell cycle arrest in G(1)-G(0). Interestingly, H2009 cells lacking Rb are resistant to miR-15a/miR-16-induced cell cycle arrest, whereas reintroduction of functional Rb resensitizes these cells to miRNA activity. In contrast, down-regulation of Rb in A549 cells by RNA interference confers resistance to these miRNAs. Thus, cell cycle arrest induced by these miRNAs depends on the expression of Rb, confirming that G(1) cyclins are major targets of miR-15a/miR-16 in NSCLC. Our results indicate that miR-15a/miR-16 are implicated in cell cycle control and likely contribute to the tumorigenesis of NSCLC.

Citing Articles

MicroRNAs in lung cancer: their role in tumor progression, biomarkers, diagnostic, prognostic, and therapeutic relevance.

Chatterjee M, Nag S, Gupta S, Mukherjee T, Shankar P, Parashar D Discov Oncol. 2025; 16(1):293.

PMID: 40067551 PMC: 11896959. DOI: 10.1007/s12672-025-02054-9.


Top 100 most-cited articles on apoptosis of non-small cell lung cancer over the past two decades: a bibliometrics analysis.

Ma L, Zhang J, Dai Z, Liao P, Guan J, Luo Z Front Immunol. 2025; 15:1512349.

PMID: 39872524 PMC: 11770037. DOI: 10.3389/fimmu.2024.1512349.


Tuberculous Pleural Effusion-Derived Exosomal miR-130b-3p and miR-423-5p Promote the Proliferation of Lung Cancer Cells via Cyclin D1.

Kang H, Yun S, Shin S, Youn D, Son G, Lee J Int J Mol Sci. 2024; 25(18).

PMID: 39337604 PMC: 11431986. DOI: 10.3390/ijms251810119.


MicroRNAs as biomarkers of brain injury in neonatal encephalopathy: an observational cohort study.

Dakroub F, Kobeissy F, Mondello S, Yang Z, Xu H, Sura L Sci Rep. 2024; 14(1):6645.

PMID: 38503820 PMC: 10951356. DOI: 10.1038/s41598-024-57166-z.


Plasma miR-195-5p predicts the severity of Covid-19 in hospitalized patients.

Moatar A, Chis A, Romanescu M, Ciordas P, Nitusca D, Marian C Sci Rep. 2023; 13(1):13806.

PMID: 37612439 PMC: 10447562. DOI: 10.1038/s41598-023-40754-w.